Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease.
Varcoe RL, DeRubertis BG, Kolluri R, Krishnan P, Metzger DC, Bonaca MP et al, for the LIFE-BTK Investigators.
N Engl J Med 2024;390: 9-19.
Some 261 patients with critical ischaemia and tibial artery disease were included. The chance of avoiding amputation, vessel occlusion or further revascularisation was higher with the scaffold: 74 vs. 44 per cent, absolute difference 30 per cent, P<0.001. Serious adverse event rates were similar.
Comment: Important study justifying the use of the drug eluting scaffold in the tibial arteries.
3 May 2024
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
